Dmitry Balyasny’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,843
Closed -$602K 1622
2020
Q1
$602K Buy
+12,843
New +$823K 0.01% 862
2019
Q2
Sell
-15,948
Closed -$829K 1830
2019
Q1
$829K Buy
+15,948
New +$735K 0.01% 1071

Dmitry Balyasny's MYOK Position: Q2 2020 in Review

Dmitry Balyasny sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 12,843 shares — an estimated $602K sold.

Dmitry Balyasny first reported a position in MYOK in Q1 2019 and held it in 2 quarters. The position peaked at $829K in Q1 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Dmitry Balyasny reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Dmitry Balyasny sold 12,843 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $602K.
  • Dmitry Balyasny first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Dmitry Balyasny's MyoKardia, Inc. Common Stock position peaked at $829K in Q1 2019.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.